Evidence map›Paper›PMID 36298554›Full record

ReviewVaccines2022

Comprehensive Highlights of the Universal Efforts towards the Development of COVID-19 Vaccine.

Riyaz Ahamed Shaik, Mohammed Shakil Ahmad, Mansour Alzahrani, Nasser A N Alzerwi, Ahmad K Alnemare, Musaed Reyzah, Haitham M Albar, Salah Alshagrawi, Ahmed M E Elkhalifa, Raed Alzahrani and 5 more

Abstract readReview
In one paragraph

Review in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Riyaz Ahamed ShaikDepartment of Family and Community Medicine, College of Medicine, Majmaah University, Al Majmaah 11952, Saudi Arabia.ORCID 0000-0003-1322-9210
Mohammed Shakil AhmadDepartment of Family and Community Medicine, College of Medicine, Majmaah University, Al Majmaah 11952, Saudi Arabia.ORCID 0000-0003-3941-7121
Mansour AlzahraniDepartment of Family and Community Medicine, College of Medicine, Majmaah University, Al Majmaah 11952, Saudi Arabia.
Nasser A N AlzerwiDepartment of Surgery, College of Medicine, Majmaah University, Ministry of Education, Al Majmaah 11952, Saudi Arabia.ORCID 0000-0002-4877-2152
Ahmad K AlnemareOtolaryngology Department, College of Medicine, Majmaah University, Al Majmaah 11952, Saudi Arabia.
Musaed ReyzahDepartment of Surgery, College of Medicine, Majmaah University, Ministry of Education, Al Majmaah 11952, Saudi Arabia.ORCID 0000-0003-2837-6141
Haitham M AlbarDepartment of Surgery, College of Medicine, Majmaah University, Ministry of Education, Al Majmaah 11952, Saudi Arabia.
Salah AlshagrawiDepartment of Public Health, College of Health Sciences, Saudi Electronic University, Riyadh 11673, Saudi Arabia.
Ahmed M E ElkhalifaDepartment of Public Health, College of Health Sciences, Saudi Electronic University, Riyadh 11673, Saudi Arabia.ORCID 0000-0002-2660-5054
Raed AlzahraniDepartment of Basic Medical Sciences, College of Medicine, Majmaah University, Al Majmaah 11952, Saudi Arabia.
Yousef AlrohaimiDepartment of Pediatrics, College of Medicine, Majmaah University, Al Majmaah 11952, Saudi Arabia.
Turki M Bin MahfozDepartment of Otolaryngology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13317, Saudi Arabia.
Ritu Kumar AhmadApplied Medical Sciences, Buraydah Private Colleges, Buraydah 51418, Saudi Arabia.
Riyadh Ahmed AlahmdiDepartment of Family Medicine, King Abdullah Bin Abdulaziz University Hospital (KAAUH), Princess Nourah Bin Abdulrahman University, Riyadh 11671, Saudi Arabia.
Nora Raid Saleem Al-BaradieCollege of Medicine, Majmaah University, Al Majmaah 11952, Saudi Arabia.ORCID 0000-0002-3230-6093

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The world has taken proactive measures to combat the pandemic since the coronavirus disease 2019 (COVID-19) outbreak, which was caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). These measures range from increasing the production of personal protective equipment (PPE) and highlighting the value of social distancing to the emergency use authorization (EUA) of therapeutic drugs or antibodies and their appropriate use; nonetheless, the disease is still spreading quickly and is ruining people's social lives, the economy, and public health. As a result, effective vaccines are critical for bringing the pandemic to an end and restoring normalcy in society. Several potential COVID-19 vaccines are now being researched, developed, tested, and reviewed. Since the end of June 2022, several vaccines have been provisionally approved, whereas others are about to be approved. In the upcoming years, a large number of new medications that are presently undergoing clinical testing are anticipated to hit the market. To illustrate the advantages and disadvantages of their technique, to emphasize the additives and delivery methods used in their creation, and to project potential future growth, this study explores these vaccines and the related research endeavors, including conventional and prospective approaches.

Indexed as

clinical trialscoronavirusCOVID-19developmentvaccine

Identifiers

PMID36298554
PMCPMC9611897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.